(Q36315252)

13 August 2017

The cognitive profile of type 1 Gaucher disease patients (English)

1 reference

13 August 2017

1 reference

Marieke Biegstraaten

1

1 reference

13 August 2017

Keith A Wesnes

2

1 reference

13 August 2017

Cécile Luzy

3

1 reference

13 August 2017

Milan Petakov

4

1 reference

13 August 2017

Mirando Mrsic

5

1 reference

13 August 2017

Claus Niederau

6

1 reference

13 August 2017

Pilar Giraldo

7

1 reference

13 August 2017

Derralynn Hughes

8

1 reference

13 August 2017

Atul Mehta

9

1 reference

13 August 2017

Karl-Eugen Mengel

10

1 reference

13 August 2017

Carla E M Hollak

11

1 reference

13 August 2017

László Maródi

12

1 reference

13 August 2017

Ivo N van Schaik

13

1 reference

13 August 2017

21 February 2012

1 reference

Journal of Inherited Metabolic Disease

13 August 2017

1 reference

13 August 2017

35

1 reference

13 August 2017

6

1 reference

13 August 2017

1093-1099

1 reference

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470680

Phenotype, diagnosis, and treatment of Gaucher's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470680

Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470680

Cognitive function testing: the case for standardization and automation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470680

Glucocerebrosidase mutations in subjects with parkinsonism

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470680

Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470680

Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470680

The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3470680

Abnormal neutrophil chemotaxis in Gaucher disease

29 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9460-7

Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9460-7

Computerized cognitive testing in patients with type I Gaucher disease: effects of enzyme replacement and substrate reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9460-7

Glucocerebrosidase mutations are an important risk factor for Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9460-7

Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9460-7

Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9460-7

Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9460-7

Medication adherence in rheumatoid arthritis patients: older is wiser.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9460-7

Enhanced calcium release in the acute neuronopathic form of Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9460-7

Neuropathology provides clues to the pathophysiology of Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9460-7

The cognitive drug research computerized assessment system for demented patients: A validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-012-9460-7

Brain white matter abnormalities in paediatric Gaucher Type I and Type III using diffusion tensor imaging

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22350617

12 December 2020

inferred from PubMed ID database lookup

Fluctuations in attention: PD dementia vs DLB with parkinsonism

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22350617

12 December 2020

inferred from PubMed ID database lookup

D-dimer assay in Gaucher disease: correlation with severity of bone and lung involvement

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22350617

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10545-012-9460-7

1 reference

release_yakrnariybhupdx7b5z6v4q37q

13 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yakrnariybhupdx7b5z6v4q37q

24 November 2022

mapped directly with Wikidata item

1 reference

13 August 2017

PubMed publication ID

22350617

1 reference